MerTK and Axl are expressed in a wide range of cancer types, including non-small cell lung cancer [10], breast cancer [11], colorectal cancer [12], ovarian cancer [13] and melanoma [14], with 50–70% of patient samples being positive. This evidence concerns the gene AXL and cancer.